内部人交易记录
董事尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Rakin Kevin, 董事. Director active across 3 companies, notably Quantum-Si Inc. Aggregated, 17 filings have been logged. Breakdown: 2 buys · 3 sells. Total volume traded: €725k. History available since 10 June 2021. The latest transaction was disclosed on 30 January 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Rakin Kevin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
70,000 股@ US$1.0673.7% 占其流量Class A Common StockSEC:0001104659-26-009295:0
50,000 股@ US$0.5199100.0% 占其流量Class A Common StockSEC:0001104659-25-123259:0
4,505,941 股Class A Common StockSEC:0001104659-25-123182:0
4,505,941 股Class A Common StockSEC:0001104659-25-122130:0
4,372,497 股Class A Common StockSEC:0001104659-25-121336:0
601,000 股0Class A Common StockSEC:0001140361-22-046663:0
89,000 股@ US$2.14870.6% 占其流量Class A Common StockSEC:0001140361-22-045863:0
10,000 股@ US$9.409616.4% 占其流量Common StockSEC:0001213900-22-014283:0
6,667 股@ US$4.805.4% 占其流量Common StockSEC:0001213900-22-008755:0
5,000 股0Common StockSEC:0001213900-22-007951:0
5,000 股0Common StockSEC:0001213900-22-007695:0
6,000 股Common StockSEC:0001213900-22-000810:0
5,000 股0Common StockSEC:0001213900-21-066053:0
21,100 股@ US$20.987272.4% 占其流量Common StockSEC:0001213900-21-048832:0
10,000 股Common StockSEC:0001213900-21-046408:0
5,697 股@ US$6.235.8% 占其流量Common StockSEC:0001213900-21-041712:0
1,901,000 股@ US$10.0098.9% 占其流量Class A Common StockSEC:0001104659-21-081583:0
About Rakin Kevin
RAKIN KEVIN is Administrateur at Oramed Pharmaceuticals INC., ELUTIA INC. and Quantum-Si Inc. He has 17 filings in total, and across the recent filings tracked between 2021-06-15 and 2026-02-02, the reported amounts are EUR 84135 on the buy side and EUR 640644 on the sell side.